Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures | NCT01268904 | Trialant
Unknown statusObservationalUpdated Dec 31, 2010
Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures
ClinicalTrials.gov ID
NCT01268904
Lead Sponsor
Hillel Yaffe Medical CenterOTHER_GOV
Overall Status
Unknown status
Study Type
Observational
Enrollment
50Estimated
Last Update Posted
Dec 31, 2010Estimated
Start Date
Jan 2011
Primary Completion Date
Jul 2013Estimated
Completion Date
Aug 2013Estimated
Brief Summary
To evaluate the safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures as part of seizure treatment protocol in pediatric ER
Status Epilepticus
Valproate
Ages Eligible for Study
Child (0-17)Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Child with clinical presentation of status epilepticus